Australian semiconductor developer BluGlass Limited (ASX: BLG) provides the following update and Appendix 4C Quarterly Report for the three months ended 31 December 2021 (Q2 FY22).
Key Highlights during the Quarter:
- Laser diode progress:
- Demonstrated performance improvements on 405nm and 420nm single-mode and multi-mode devices
- Continued progress towards delivering four key components needed for reliable laser diodes
- Exhibited latest laser diode performance data at leading industry conference, Photonics West
- Secured six-month epitaxy foundry agreement with European wafer developer for power electronics applications
The full report is available to download here: FOR RELEASE BLG December Quarter Report and App 4C 28.01.22
About BluGlass
Developing leading-edge semiconductor manufacturing technology and devices for more than a decade, BluGlass Limited (ASX:BLG) is a leading supplier of GaN laser diode products to the global photonics industry, focused on the industrial, defence, bio-medical, and scientific markets.
Listed on the ASX, BluGlass is one of just a handful of end-to-end GaN laser manufacturers globally. Its operations in Australia and the USA offer cutting-edge, custom laser diode development and manufacturing, from small-batch custom lasers to medium and high-volume off-the-shelf products.
The Company combines its proprietary low temperature, low hydrogen, remote plasma chemical vapour deposition (RPCVD) manufacturing process with advanced device design and fabrication to deliver differentiated laser solutions. With end-to-end capabilities spanning epitaxy, device design, fabrication, and testing, BluGlass is well-positioned to support critical next-generation photonics applications and sovereign supply chains.
For more information, please contact:
Stefanie Winwood
+61293342300 |swinwood@bluglass.com
James Lennon, Automic Markets
+61414035704 |james.lennon@automicgroup.com.au
Samuel Samhan, BluGlass CFO
ssamhan@bluglass.com
